AgomAb Therapeutics NV
Biotechnology company · Antwerpen, Flanders, Belgium · Nasdaq: AGMB
AgomAb Therapeutics NV is a biotechnology company headquartered in Antwerpen, Flanders, Belgium. Its shares trade on Nasdaq under the ticker AGMB.
Profile compiled from public records. Is this your company? Request a correction or update
AgomAb Therapeutics at a glance
Typebiotechnology company
HeadquartersAntwerpen, Flanders, Belgium
Stock listingNasdaq: AGMB
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK2020932
Frequently asked questions about AgomAb Therapeutics
Where is AgomAb Therapeutics headquartered?
AgomAb Therapeutics NV is headquartered in Antwerpen, Flanders, Belgium.
What does AgomAb Therapeutics do?
AgomAb Therapeutics NV is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is AgomAb Therapeutics a public company?
Yes. AgomAb Therapeutics NV trades on Nasdaq under the ticker AGMB.
Similar companies
- Ablynx NVGent, Flanders, Belgium
- Fluidda NVKontich, Flanders, Belgium
- Argenx SeZwijnaarde, Flanders, Belgium
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences